| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner
1 company
Innoviva, Inc. last filed a Form 4 in January 2023, as Director, 10% Owner at ARMP.
At the last filing, the largest reported position was 16,365,969 shares of ARMP. Net of sales, the ARMP filings show accumulation of 24,083,630 shares.
Innoviva, Inc. has 7 Form 4 filings on record from March 2020 to January 2023, all as Director, 10% Owner at Armata Pharmaceuticals (ARMP), 2020–2023.
The 12 reported transactions were 12 open-market purchases.
Counted by filing, the open-market trades come to 6 purchases worth about $91.1M and no sales.
The largest open-market purchase was 5,385,208 shares of ARMP at an average $5.00 on March 31, 2022, about $26.9M.
Shares as reported in the last Form 4 for each company; the most recent is from January 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | ARMP Armata Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 5,385,208 | $5.00 | $26,926,040.00 | +49.0% | |
| Feb 9, 2022 | ARMP Armata Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 3,614,792 | $5.00 | $18,073,960.00 | +49.1% | |
| Oct 29, 2021 | ARMP Armata Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 1,212,122 | $3.30 | $4,000,002.60 | +19.7% | |
| Mar 17, 2021 | ARMP Armata Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 4,285,935 | $3.25 | $13,929,288.75 | +229.5% | |
| Jan 26, 2021 | ARMP Armata Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 1,867,912 | $3.25 | $6,070,714.00 | New | |
| Mar 27, 2020 | ARMP Armata Pharmaceuticals, Inc. | 10% Owner | Buy | 7,717,661 | $2.87 | $22,149,687.07 | +777.1% |